In a remarkable advancement in the field of biomedical research, scientists at École Polytechnique Fédérale de Lausanne (EPFL) have developed ultra-selective aptamers that imitate viral attachment mechanisms to enhance diagnostic and therapeutic applications. Aptamers, short nucleic acid sequences that can bind to specific targets, are being re-engineered to achieve unprecedented binding affinities and selectivity.

Aptamers: A New Frontier in Diagnostics and Therapeutics

Aptamers serve as synthetic alternatives to antibodies thanks to their cost-effectiveness and simplicity in production. They can be designed to target a variety of biomolecules, making them valuable in the realms of diagnostics and therapy. Traditionally, aptamers developed from nucleic acid libraries have been monovalent, meaning they bind to a single site on a target molecule. This limitation is particularly problematic when interacting with complex viral structures such as the spike proteins of SARS-CoV-2, influenza, and HIV, all of which consist of multiple identical subunits.

Challenges of Monovalent Bindings

According to Maartje Bastings, head of the Programmable Biomaterials Lab at EPFL, using monovalent binders can often yield imprecise results akin to "throwing a bowl of spaghetti at the wall." An aptamer may attach to a non-functional site on a target protein, reducing its overall efficacy.

Innovative Approach: MEDUSA

In response to these challenges, Bastings and her team have introduced a new technique named MEDUSA (Multivalent Evolved DNA-based SUpramolecular Assemblies). This innovative method allows for the formation of multimeric aptamers designed specifically to match the spatial geometry of target proteins, yielding binder affinities that are between 10 and 1,000 times stronger than those produced from monovalent approaches.

Key Features of MEDUSA

  • Functionality: Aptamers developed using MEDUSA exhibit enhanced functionality, crucial for precise diagnostics.
  • Binding Affinity: The multimeric design provides greater specificity in targeting proteins.
  • Scaffold Design: The aptamers are based on tailored scaffolds which enhance the natural assembly of binding units.

A Bioinspired Methodology

The structural design of the MEDUSA scaffolds emulates the geometry of the SARS-CoV-2 spike protein, allowing for efficient binding right at the functional interface of target proteins. This bioinspired approach enables a more organized search for effective multivalent binders.

“We have retro-engineered the natural paradigm seen in viruses,” notes Ph.D. student Artem Kononenko, the first author of the study, underscoring the innovative aspects of this research.

Future Directions

The evolutionary process to select and amplify candidates can take weeks, a timeline that the researchers aim to shorten for more timely application in diagnostics and therapeutics. Furthermore, the team plans to expand the variety of multivalent binders to target pathogens with even more complex structures, such as those seen in Dengue fever and anthrax.

Ultimately, Bastings envisions leveraging generative artificial intelligence to streamline the development of these multimeric binders in the future.

Publication and Additional Information

The findings of this groundbreaking research have been documented in a publication in Nature Nanotechnology.

For more detailed insights, refer to the study: Ultra-selective aptamers give viruses a taste of their own medicine.

Research Summary

Aspect Description Range of Improvement
Binding Affinity Strength of binding between the aptamer and its target 10 - 1,000 times stronger than monovalent aptamers
Selectivity Ability to bind exclusively to the target protein Significantly enhanced for viral proteins
Scaffold Technology Design of aptamer scaffolds emulating viral geometries Custom-designed to fit target proteins structurally

Conclusion

The development of multi-layered, ultra-selective aptamers represents a significant leap forward in the quest for effective tools in combating viral infections. By imitating the natural bonding patterns of viruses, this innovative approach could enhance both diagnostic accuracy and therapeutic effectiveness in fields currently limited by existing monovalent binding technologies. The applications of such advancements in real-world scenarios promise to reshape our understanding and management of viral diseases.

References

Kononenko, A. et al. Evolution of multivalent supramolecular assemblies of aptamers with target-defined spatial organization, Nature Nanotechnology (2025).